This company listing is no longer active
4D pharma Past Earnings Performance
Past criteria checks 0/6
Key information
-4.7%
Earnings growth rate
29.5%
EPS growth rate
Biotechs Industry Growth | 11.5% |
Revenue growth rate | 4.1% |
Return on equity | -98.5% |
Net Margin | -4,448.2% |
Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How 4D pharma makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 21 | 1 | -32 | 16 | 22 |
30 Sep 21 | 1 | -36 | 15 | 21 |
30 Jun 21 | 1 | -41 | 15 | 21 |
31 Mar 21 | 1 | -36 | 14 | 22 |
31 Dec 20 | 1 | -30 | 13 | 23 |
30 Sep 20 | 1 | -30 | 13 | 26 |
30 Jun 20 | 1 | -30 | 13 | 29 |
31 Mar 20 | 0 | -30 | 12 | 29 |
31 Dec 19 | 0 | -30 | 10 | 29 |
30 Sep 19 | 0 | -31 | 8 | 29 |
30 Jun 19 | 0 | -32 | 6 | 30 |
31 Mar 19 | 0 | -32 | 6 | 32 |
31 Dec 18 | 0 | -30 | 6 | 32 |
30 Sep 18 | 0 | -28 | 6 | 29 |
30 Jun 18 | 0 | -25 | 6 | 27 |
31 Mar 18 | 0 | -28 | 6 | 26 |
31 Dec 17 | 0 | -28 | 5 | 23 |
30 Sep 17 | 0 | -25 | 4 | 21 |
30 Jun 17 | 0 | -22 | 3 | 18 |
31 Mar 17 | 0 | -17 | 3 | 15 |
31 Dec 16 | 0 | -12 | 4 | 12 |
30 Sep 16 | 0 | -12 | 5 | 12 |
30 Jun 16 | 0 | -11 | 5 | 11 |
Quality Earnings: DDDD is currently unprofitable.
Growing Profit Margin: DDDD is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if DDDD's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare DDDD's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DDDD is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.5%).
Return on Equity
High ROE: DDDD has a negative Return on Equity (-98.53%), as it is currently unprofitable.